Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion Sabag Mark acquired 52,113 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Hughes Eric A sold 11,277 shares at $32.46 ($366,102)
  6. 4 Exercise or conversion EVP, Chief Financial Officer acquired 56,763 shares (option exercise)
  7. 4 Planned sale EVP, U.S. Commercial sold 9,098 shares at $32.46 ($295,362)
  8. 4 Open-market sale Interim Chief Legal Officer sold 2,675 shares at $32.46 ($86,843)
  9. 4 Exercise or conversion Chief Accounting Officer acquired 16,329 shares (option exercise)
  10. 4 Exercise or conversion Chief Accounting Officer acquired 5,179 shares (option exercise)
  11. 4 Planned sale EVP, Europe Commercial sold 128,985 shares at $32.36 ($4,173,942)
  12. 4 Exercise or conversion Sabag Mark acquired 166,378 shares (option exercise)
  13. 4 Open-market sale Interim Chief Legal Officer sold 1,274 shares at $32.36 ($41,227)
  14. 4 Planned sale President and CEO sold 442,935 shares at $32.36 ($14,333,332)
  15. 4 Exercise or conversion EVP, Chief Financial Officer acquired 191,278 shares (option exercise)
  16. 4 Planned sale Hughes Eric A sold 80,762 shares at $32.36 ($2,613,450)
  17. 4 Planned sale EVP, Chief Financial Officer sold 345,810 shares at $33.64 ($11,634,708)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale President and CEO sold 447,778 shares at $34.22 ($15,324,799)
  20. 4 Derivatives Options or other derivatives

Page 4 of 34 · 666 filings